门冬氨酸钾镁与胺碘酮联合治疗急性心肌梗死室性心律失常的疗效分析

Effect of Potassium Magnesium Aspartate Combined with Amiodarone on Ventricular Arrhythmia in Patients with Acute Myocardial Infarction

目的:研究对急性心肌梗死(AMI)室性心律失常患者运用胺碘酮与门冬氨酸钾镁联合用药方案的治疗效果。方法:从2018年2月—2019年5月在本院治疗的急性心肌梗死患者中选取64例为研究对象,均合并有室性心律失常,随机分为对照组与观察组,各32例。对照组药物为胺碘酮,观察组药物为胺碘酮与门冬氨酸钾镁,评估疗效与用药安全性。结果:观察组治疗总有效率为96.9%,明显高于对照组81.3%(P<0.05),差异存在统计学意义;对比不良反应发生率,组间差异不显著(P>0.05)不存在统计学意义。结论:对急性心肌梗死室性心律失常患者可采用胺碘酮与门冬氨酸钾镁联合用药方案,效果显著,安全可靠。

Objective:To study the effect of amiodarone combined with potassium magnesium aspartate in the treatment of ventricular arrhythmia in patients with acute myocardial infarction(AMI).Method:From February 2018 to may 2019,64 patients with acute myocardial infarction treated in our hospital were selected as the study objects,all of them were combined with ventricular arrhythmia,and randomly divided into the control group and the observation group,32 cases each.Amiodarone was used in the control group,amiodarone and potassium magnesium aspartate were used in the observation group.Result:The total effective rate of the observation group was 96.9%,significantly higher than that of the control group(81.3%)(P<0.05),the difference was statistically significant;the incidence of adverse reactions was not statistically significant(P>0.05).Conclusion:The combination of amiodarone and potassium magnesium aspartate is effective,safe and reliable for patients with acute myocardial infarction and ventricular arrhythmia.